Affinity Asset Advisors: Funding, Team & Investors | Startup Intros

Loading organizations...

Affinity Asset Advisors: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 1, 2025	Odyssey Therapeutics	$210.0M Series D	—	Dimension Capital, General Catalyst, OrbiMed, SR One, Third Rock Ventures, Rafaèle Tordjman, Shelley Chu, Paulina Hill, Carolyn Ng, Wedbush Healthcare Partners
Jan 1, 2022	Ceptur Therapeutics	$75.0M Series A	Colin Walsh	venBio, Vivo Capital, Evan Cheng, Daniel Heller, Boxer Capital, Bristol Myers Squibb, Janus Henderson Investors, LifeSci Venture Partners, Perceptive Xontogeny Venture Fund
Jun 10, 2021	Kurome Therapeutics	$15.0M Series A	Daniel Heller, Aaron Kantoff	CincyTech
May 1, 2021	Hummingbird Bioscience	$130.0M Series C	Ken Harrison	Frazier Healthcare Partners, Ally Bridge Group, Altrium Capital Management, Amgen Ventures, Droia Ventures, EDBI, Heritas Capital, Mirae Asset, Morningside Ventures, Octagon Capital, Polaris Partners, Pureos Bioventures, Kiel Kim